The IHC revealed that the tumors were positive for myeloperoxidase (MPO++), CD34 (+++), CD43 (+++), CD68 (+), CD117 (+), and Ki67 (40%+), which are markers of myeloid tumors (Fig. 3A-D). Here, MPO is linked to myeloid neoplasm.